- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Adaptive Approach to Clinical Trials
The design of clinical trials and the volume of pharmacogenomics data being generated present challenges to the development and success of future treatment options.
Irwin W. Tischler, DO, suggests that an adaptive approach to clinical trial design can accelerate the development of new agents. He explains that having the capability to modify the design of a trial based upon preliminary results, on an as-you-go basis, may help speed the clinical trial process. For example, based on initial data, the dose of a drug used might be changed during the course of the trial, or the patient population might be modified to include patients who would benefit most.
Dr Tischler adds that pharmacogenetic testing is associated with financial challenges. He explains that testing often involves more than 200 genetic markers; however, only 20 genetic markers are presently actionable. Thus, large amounts of money are being invested on information that is not clinically relevant.
Watch our related Peer Exchange, Oncology Stakeholder Summit 2014: Evidence-Based Decisions to Improve Quality and Regulate Costs
A Focus on MAHA, Lasting Changes to Health Care Programs for Trump’s Second Term
March 13th 2025The second Trump administration is expected to bring changes to Medicaid, Medicare Advantage, and the health insurance exchanges, as well as highlight the Make America Healthy Again (MAHA) movement, speakers at the Value-Based Insurance Design Summit said.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Shaping Dermatology's Future by Increasing Access, Data, and Advocacy
March 7th 2025Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
Read More
